December 22, 2011

Drug maker Actavis is partnering with QRxPharma to sell what the former called a novel pain drug in the United States.

December 22, 2011

A Pfizer painkiller appears to produce a much less positive experience for recreational drug users when crushed than when administered whole, according to results of a post-marketing clinical study program.

December 15, 2011

Approximately 5.3% of high school seniors abused over-the-counter cough-cold medicines in the past month, according to the latest "Monitoring the Future" survey released Wednesday by the National Institute on Drug Abuse.

December 13, 2011

A new law in Washington state intended to curb accidental deaths related to opioid painkillers is having some adverse side effects, according to published reports.

December 12, 2011

The Food and Drug Administration has approved a new formulation of a painkiller made by Endo Pharmaceuticals designed to thwart drug abuse, Endo said Monday.

December 12, 2011

The Food and Drug Administration has approved a generic painkiller made by Sun Pharmaceutical Industries, Sun said.

December 1, 2011

Actavis is in the process of bringing FeverAll acetaminophen suppositories back to the market, the company announced. FeverAll had been unavailable while changes were being made at the product's manufacturing facility.

November 21, 2011

Drug maker Impax Labs is looking to challenge the patent protection on a drug used to treat pain related to cancer, the company said Monday.

November 15, 2011

Actavis has launched an authorized generic drug for treating pain, the company said.

November 14, 2011

The Food and Drug Administration has approved a generic drug for treating pain.

November 11, 2011

Watson Pharmaceuticals has launched its generic version of an opioid drug for treating pain, the company said Thursday.

November 8, 2011

Purdue Pharma has launched a new way for fighting pharmacy crime, the drug maker said Tuesday.

October 27, 2011

Mylan has received final approval from the Food and Drug Administration for a drug designed to treat moderate to severe pain.

October 18, 2011

Johnson & Johnson Tuesday morning pledged significant support behind the relaunch of several McNeil Consumer products into the marketplace in 2012, and feels confident impacted brands — Tylenol and Motrin, among others — will be able to recapture market share, despite significant private-label erosion.

October 17, 2011

Archimedes Pharma has launched a new drug for breakthrough cancer pain, the drug maker said Monday.

October 17, 2011

Lannett announced that it has begun shipping three generic drugs that recently were approved by the Food and Drug Administration.

October 10, 2011

The Federal Trade Commission has given Teva Pharmaceutical Industries the green light to acquire Frazer, Pa.-based drug maker Cephalon, but with some restrictions, Teva said.

October 5, 2011

AccuDial Pharmaceutical on Tuesday acquired Stephen Key Design in a move that will expand AccuDial’s patent portfolio to more than 50 patents for weight-based dosing and other extended content rotating labels, which add 75% more labeling space to a container.

October 4, 2011

Amneal last month launched its version of an epilepsy treatment.

September 26, 2011

With Tylenol coming back to cough-cold and analgesic aisles over the next six months, you can bet the brand will soon resume its status as the cleanup hitter for Team OTC. That not only means a reshuffling of the lineup, but the respective No. 9 hitters will be packing their bags for a trip back to the minors.

September 22, 2011

It seems that Tylenol Cold & Flu Severe caplets are making their way back to store shelves, according to published reports.

September 12, 2011

Perrigo this summer developed a healthcare professional outreach strategy, educating pediatricians, for example, around the company’s new infants’ and children’s acetaminophen dosing and packaging changes.

September 9, 2011

The Food and Drug Administration has approved a generic drug made by Mylan for treating allergies.

September 1, 2011

Proton-pump inhibitors may aggravate, not soothe, stomach discomfort created through chronic use of nonsteroidal anti-inflammatory drugs for such conditions as arthritis, according to research released Thursday.